• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未铺砌道路:DNA 损伤反应如何应对内源性遗传毒物。

Unpaved roads: How the DNA damage response navigates endogenous genotoxins.

机构信息

Department of Cancer Biology, Penn Center for Genome Integrity, Basser Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA.

Department of Cancer Biology, Penn Center for Genome Integrity, Basser Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USA.

出版信息

DNA Repair (Amst). 2022 Oct;118:103383. doi: 10.1016/j.dnarep.2022.103383. Epub 2022 Aug 2.

DOI:10.1016/j.dnarep.2022.103383
PMID:35939975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9703833/
Abstract

Accurate DNA repair is essential for cellular and organismal homeostasis, and DNA repair defects result in genetic diseases and cancer predisposition. Several environmental factors, such as ultraviolet light, damage DNA, but many other molecules with DNA damaging potential are byproducts of normal cellular processes. In this review, we highlight some of the prominent sources of endogenous DNA damage as well as their mechanisms of repair, with a special focus on repair by the homologous recombination and Fanconi anemia pathways. We also discuss how modulating DNA damage caused by endogenous factors may augment current approaches used to treat BRCA-deficient cancers. Finally, we describe how synthetic lethal interactions may be exploited to exacerbate DNA repair deficiencies and cause selective toxicity in additional types of cancers.

摘要

准确的 DNA 修复对于细胞和机体的稳态至关重要,而 DNA 修复缺陷会导致遗传疾病和癌症易感性。紫外线等一些环境因素会破坏 DNA,但许多其他具有 DNA 损伤潜力的分子是正常细胞过程的副产品。在这篇综述中,我们重点介绍了一些主要的内源性 DNA 损伤来源及其修复机制,特别关注同源重组和范可尼贫血途径的修复。我们还讨论了如何调节内源性因素引起的 DNA 损伤,以增强目前用于治疗 BRCA 缺陷型癌症的方法。最后,我们描述了如何利用合成致死相互作用来加剧 DNA 修复缺陷,并在其他类型的癌症中引起选择性毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335c/9703833/2e4fa9c0362a/nihms-1850353-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335c/9703833/aa25a636eceb/nihms-1850353-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335c/9703833/2e4fa9c0362a/nihms-1850353-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335c/9703833/aa25a636eceb/nihms-1850353-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335c/9703833/2e4fa9c0362a/nihms-1850353-f0002.jpg

相似文献

1
Unpaved roads: How the DNA damage response navigates endogenous genotoxins.未铺砌道路:DNA 损伤反应如何应对内源性遗传毒物。
DNA Repair (Amst). 2022 Oct;118:103383. doi: 10.1016/j.dnarep.2022.103383. Epub 2022 Aug 2.
2
DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target.DNA 修复:利用范可尼贫血途径作为潜在的治疗靶点。
Physiol Res. 2011;60(3):453-65. doi: 10.33549/physiolres.932115. Epub 2011 Mar 14.
3
Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.范可尼贫血:关于流行病学、癌症和DNA修复的当前见解。
Hum Genet. 2022 Dec;141(12):1811-1836. doi: 10.1007/s00439-022-02462-9. Epub 2022 May 21.
4
Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology.鉴定和利用肿瘤中范可尼贫血/BRCA 通路的缺陷
Transl Res. 2012 Sep;160(3):178-97. doi: 10.1016/j.trsl.2012.01.022. Epub 2012 Feb 9.
5
Crosstalk between the nucleotide excision repair and Fanconi anemia/BRCA pathways.核苷酸切除修复与范可尼贫血/BRCA通路之间的串扰。
DNA Repair (Amst). 2014 Jul;19:130-4. doi: 10.1016/j.dnarep.2014.03.019. Epub 2014 Apr 24.
6
Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48.范可尼贫血症 DNA 修复途径的综合拯救相互作用图谱鉴定 USP48。
Nat Commun. 2018 Jun 11;9(1):2280. doi: 10.1038/s41467-018-04649-z.
7
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.范可尼贫血/BRCA 通路对 DNA 交联修复的调控。
Genes Dev. 2012 Jul 1;26(13):1393-408. doi: 10.1101/gad.195248.112.
8
Fanconi anemia proteins and endogenous stresses.范可尼贫血蛋白与内源性应激
Mutat Res. 2009 Jul 31;668(1-2):42-53. doi: 10.1016/j.mrfmmm.2009.03.013.
9
The Fanconi anemia pathway in replication stress and DNA crosslink repair.复制应激和DNA交联修复中的范可尼贫血途径。
Cell Mol Life Sci. 2012 Dec;69(23):3963-74. doi: 10.1007/s00018-012-1051-0. Epub 2012 Jun 29.
10
The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.BRCA基因在DNA修复中的作用与癌症易感性之间的关系。
Trends Mol Med. 2002 Dec;8(12):571-6. doi: 10.1016/s1471-4914(02)02434-6.

引用本文的文献

1
Phase separation in DNA repair: orchestrating the cellular response to genomic stability.DNA修复中的相分离:协调细胞对基因组稳定性的反应
PeerJ. 2025 May 2;13:e19402. doi: 10.7717/peerj.19402. eCollection 2025.
2
The cGAS-STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts.在缺乏 ATM 的小鼠肺成纤维细胞中,cGAS-STING 通路、p38 丝裂原活化蛋白激酶(p38 MAPK)通路和 p53 通路将基因组不稳定性与细胞衰老加速联系起来。
Proc Natl Acad Sci U S A. 2025 Jan 14;122(2):e2419196122. doi: 10.1073/pnas.2419196122. Epub 2025 Jan 7.
3
Broad repression of DNA repair genes in senescent cells identified by integration of transcriptomic data.

本文引用的文献

1
The CIP2A-TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer.CIP2A-TOPBP1 轴确保染色体稳定性,是 BRCA 突变型癌症的合成致死靶点。
Nat Cancer. 2021 Dec;2(12):1357-1371. doi: 10.1038/s43018-021-00266-w. Epub 2021 Nov 11.
2
Tackling PARP inhibitor resistance.应对 PARP 抑制剂耐药性。
Trends Cancer. 2021 Dec;7(12):1102-1118. doi: 10.1016/j.trecan.2021.08.007. Epub 2021 Sep 22.
3
Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.
通过转录组数据整合鉴定出衰老细胞中DNA修复基因的广泛抑制。
Nucleic Acids Res. 2025 Jan 7;53(1). doi: 10.1093/nar/gkae1257.
4
The Smc5/6 complex counteracts R-loop formation at highly transcribed genes in cooperation with RNase H2.Smc5/6复合物与核糖核酸酶H2协同作用,抑制高转录基因处R环的形成。
Elife. 2024 Oct 15;13:e96626. doi: 10.7554/eLife.96626.
5
Elucidation of the molecular mechanism of the breakage-fusion-bridge (BFB) cycle using a CRISPR-dCas9 cellular model.利用 CRISPR-dCas9 细胞模型阐明断裂-融合-桥接(BFB)循环的分子机制。
Nucleic Acids Res. 2024 Oct 28;52(19):11689-11703. doi: 10.1093/nar/gkae747.
6
Replication stress as a driver of cellular senescence and aging.复制压力作为细胞衰老和老化的驱动因素。
Commun Biol. 2024 May 22;7(1):616. doi: 10.1038/s42003-024-06263-w.
7
The mitochondrial ATP-dependent potassium channel (mitoK) controls skeletal muscle structure and function.线粒体 ATP 依赖性钾通道(mitoK)控制骨骼肌的结构和功能。
Cell Death Dis. 2024 Jan 17;15(1):58. doi: 10.1038/s41419-024-06426-x.
核 DNA 连接酶 III 的缺失通过暴露单链 DNA 缺口使 BRCA1/53BP1 双缺陷细胞对 PARP 抑制剂耐药性逆转。
Mol Cell. 2021 Nov 18;81(22):4692-4708.e9. doi: 10.1016/j.molcel.2021.09.005. Epub 2021 Sep 22.
4
REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.REV1-Polζ 通过修复 PRIMPOL 依赖性单链 DNA 缺口来维持同源重组缺陷型癌细胞的活力。
Mol Cell. 2021 Oct 7;81(19):4008-4025.e7. doi: 10.1016/j.molcel.2021.08.016. Epub 2021 Sep 10.
5
Understanding and overcoming resistance to PARP inhibitors in cancer therapy.理解和克服癌症治疗中对 PARP 抑制剂的耐药性。
Nat Rev Clin Oncol. 2021 Dec;18(12):773-791. doi: 10.1038/s41571-021-00532-x. Epub 2021 Jul 20.
6
The WRN helicase: resolving a new target in microsatellite unstable cancers.WRN 解旋酶:在微卫星不稳定癌症中解决新靶点。
Curr Opin Genet Dev. 2021 Dec;71:34-38. doi: 10.1016/j.gde.2021.06.014. Epub 2021 Jul 17.
7
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.复制间隙是 PARP 抑制剂与 BRCA 缺陷合成致死性的关键决定因素。
Mol Cell. 2021 Aug 5;81(15):3128-3144.e7. doi: 10.1016/j.molcel.2021.06.011. Epub 2021 Jul 2.
8
A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors.一种一流的聚合酶θ抑制剂选择性靶向同源重组缺陷型肿瘤。
Nat Cancer. 2021 Jun;2(6):598-610. doi: 10.1038/s43018-021-00203-x. Epub 2021 Jun 17.
9
TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells.TERRA 转录物使端粒完整性不稳定,从而在人类 ALT 细胞中引发断裂诱导复制。
Nat Commun. 2021 Jun 18;12(1):3760. doi: 10.1038/s41467-021-24097-6.
10
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.聚(ADP-核糖)聚合酶抑制剂能引发 BRCA 基因合成致死,并靶向聚 ADP 核糖聚合酶抑制剂耐药性。
Nat Commun. 2021 Jun 17;12(1):3636. doi: 10.1038/s41467-021-23463-8.